204 related articles for article (PubMed ID: 24162628)
1. Variation in the use of medicines by ethnicity during 2006/07 in New Zealand: a preliminary analysis.
Metcalfe S; Laking G; Arnold J
N Z Med J; 2013 Oct; 126(1384):14-41. PubMed ID: 24162628
[TBL] [Abstract][Full Text] [Related]
2. Does mortality vary between pacific groups in New Zealand? Estimating Samoan, Cook Island Maori, Tongan, and Niuean mortality rates using hierarchical Bayesian modelling.
Blakely T; Richardson K; Young J; Callister P; Didham R
N Z Med J; 2009 Dec; 122(1307):18-29. PubMed ID: 20148041
[TBL] [Abstract][Full Text] [Related]
3. Te Wero tonu-the challenge continues: Māori access to medicines 2006/07-2012/13 update.
Metcalfe S; Beyene K; Urlich J; Jones R; Proffitt C; Harrison J; Andrews Ā
N Z Med J; 2018 Nov; 131(1485):27-47. PubMed ID: 30408816
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant dispensing trends in New Zealand between 2004 and 2007.
Exeter D; Robinson E; Wheeler A
Aust N Z J Psychiatry; 2009 Dec; 43(12):1131-40. PubMed ID: 20001412
[TBL] [Abstract][Full Text] [Related]
5. Does access to medicines differ by gender? Evidence from 15 low and middle income countries.
Stephens P; Ross-Degnan D; Wagner AK
Health Policy; 2013 Apr; 110(1):60-6. PubMed ID: 23422029
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
Peiris D; Murray J; Scully D; Tilakawardene V; Hetaraka-Stevens L; Stewart T; Patel A
N Z Med J; 2008 Nov; 121(1285):35-46. PubMed ID: 19079435
[TBL] [Abstract][Full Text] [Related]
7. Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New Zealand.
Metcalfe S; Moodie P; Norris H; Rasiah D
N Z Med J; 2014 Nov; 127(1406):48-62. PubMed ID: 25447249
[TBL] [Abstract][Full Text] [Related]
8. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
Huria T; Palmer S; Beckert L; Williman J; Pitama S
Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
[TBL] [Abstract][Full Text] [Related]
9. Access and society as determinants of ischaemic heart disease in indigenous populations.
Curtis E; Harwood M; Riddell T; Robson B; Harris R; Mills C; Reid P
Heart Lung Circ; 2010; 19(5-6):316-24. PubMed ID: 20444647
[TBL] [Abstract][Full Text] [Related]
10. Equity in statin use in New Zealand.
Norris P; Horsburgh S; Becket G; Keown S; Arroll B; Lovelock K; Crampton P; Cumming J; Herbison P
J Prim Health Care; 2014 Mar; 6(1):17-22. PubMed ID: 24624407
[TBL] [Abstract][Full Text] [Related]
11. The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study.
Mehta S; Wells S; Jackson R; Harrison J; Kerr A
N Z Med J; 2016 Oct; 129(1443):18-29. PubMed ID: 27736849
[TBL] [Abstract][Full Text] [Related]
12. Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring Programme.
Hill GR; Ashton J; Harrison-Woolrych M
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1217-26. PubMed ID: 17661435
[TBL] [Abstract][Full Text] [Related]
13. Unlocking the numerator-denominator bias. II: Adjustments to mortality rates by ethnicity and deprivation during 1991-94. The New Zealand Census-Mortality Study.
Blakely T; Kiro C; Woodward A
N Z Med J; 2002 Feb; 115(1147):43-8. PubMed ID: 11942514
[TBL] [Abstract][Full Text] [Related]
14. IDI trends in antidepressant dispensing to New Zealand children and young people between 2007/08 and 2015/16.
Bowden N; Gibb S; Thabrew H; Audas R; Camp J; Taylor B; Hetrick S
N Z Med J; 2019 Nov; 132(1505):48-61. PubMed ID: 31697663
[TBL] [Abstract][Full Text] [Related]
15. Sore throat management in New Zealand general practice.
Kljakovic M; Crampton P
N Z Med J; 2005 Aug; 118(1220):U1609. PubMed ID: 16132070
[TBL] [Abstract][Full Text] [Related]
16. Effect of age, gender, ethnicity, socioeconomic status and region on dispensing of CVD secondary prevention medication in New Zealand: the Atlas of Health Care Variation CVD cohort (VIEW-1).
Kerr A; Exeter D; Hanham G; Grey C; Zhao J; Riddell T; Lee M; Jackson R; Wells S
N Z Med J; 2014 Aug; 127(1400):39-69. PubMed ID: 25145366
[TBL] [Abstract][Full Text] [Related]
17. Ethnicity and access to prescription medicines.
Horsburgh S; Norris P
N Z Med J; 2013 Oct; 126(1384):7-11. PubMed ID: 24162626
[No Abstract] [Full Text] [Related]
18. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
Sundborn G; Metcalf P; Scragg R; Schaaf D; Dyall L; Gentles D; Black P; Jackson R
N Z Med J; 2007 Jun; 120(1257):U2607. PubMed ID: 17632597
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of ovarian cancer in women residing in Aotearoa, New Zealand: 1993-2004.
Firestone RT; Wong KC; Ellison-Loschmann L; Pearce N; Jeffreys M
J Epidemiol Community Health; 2009 Oct; 63(10):814-9. PubMed ID: 19574244
[TBL] [Abstract][Full Text] [Related]
20. Ethnic disparities in community antibacterial dispensing in New Zealand, 2015.
Whyler N; Tomlin A; Tilyard M; Thomas M
N Z Med J; 2018 Aug; 131(1480):50-60. PubMed ID: 30116065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
